Protein Binding of Quinolonecarboxylic Acids. II. : Spectral Changes on the Interaction of Cinoxacin, Nalidixic Acid and Pipemidic Acid with Human and Rat Albumins
The interaction of cinoxacin (CINX), nalidixic acid (NA), and pipemidic acid (PPA) with human and rat serum albumins (HSA and RSA) was studied by UV difference absorption and circular dichroism (CD) spectroscopy. CINX and NA bound to the albumins and generated difference absorption and induced CD (I...
Gespeichert in:
Veröffentlicht in: | Chemical & pharmaceutical bulletin 1989/03/25, Vol.37(3), pp.746-752 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 752 |
---|---|
container_issue | 3 |
container_start_page | 746 |
container_title | Chemical & pharmaceutical bulletin |
container_volume | 37 |
creator | IZUMI, Taro NAGAYAMA, Takako KITAGAWA, Takayasu |
description | The interaction of cinoxacin (CINX), nalidixic acid (NA), and pipemidic acid (PPA) with human and rat serum albumins (HSA and RSA) was studied by UV difference absorption and circular dichroism (CD) spectroscopy. CINX and NA bound to the albumins and generated difference absorption and induced CD (ICD) spectra. The difference absorption spectral data explained reasonably our previous observations that CINX bound to HSA more weakly than NA, but to RSA as strongly as NA. We used a quantity Δε/ε, designated as relative molar difference absorbance, at positions corresponding to the longest wavelength peaks in the difference spectra. The quantity was found to correlate linearly with percent bound to both HSA and RSA, but with different slopes, from which the binding site for CINX and NA in RSA was supposed to provide a much more nonpolar environment than that in HSA. The magnitude of ICD bands observed at 371 nm for CINX and at 342-348 nm for NA corresponded to the binding degrees of these drugs to both albumins. Anisotropy factors for the ICD bands at 350-271 nm for CINX and 320-348 nm for NA were approximately similar between HSA and RSA, suggesting a similar ability to generate the ICD spectra in these wavelength regions upon binding to the albumins. Spectral results for PPA in albumin solutions showed little or no binding of this drug to HSA and RSA. PPA existed as a betaine form in neutral solution and its positively charged group acted as an unfavorable factor for binding to both albumins. |
doi_str_mv | 10.1248/cpb.37.746 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79104063</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79104063</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4496-b7d4a247c2a92fee2278c78f5359344e052d9ec0b8103b9e06d383fbd6553a5b3</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhSMEKtPChj2SN7BAZHD8EyfshqjQkSoof-voxrmZcZU4wXbE9Hl4UTxM1C7Z2PI9n7-7OEnyIqPrjIninZ6aNVdrJfJHySrjQqWSMf44WVFKy5TxnD9Nzr2_pZRJqvhZcsaUjB-LVfLnxo0BjSUfjG2N3ZGxI19nY8d-tKjBNePhrjeabLRp_Zpst2vynnyfUAcHPan2YHfoyWhJ2CPZ2oAOdDDxHT1V1BxAG_uWfIbetOawiAjYltyYCYc4XEa_TdiTq3kA-y_9BoFs-mYejPXPkicd9B6fL_dF8vPj5Y_qKr3-8mlbba5TLUSZp41qBTChNIOSdYiMqUKropNcllwIpJK1JWraFBnlTYk0b3nBu6bNpeQgG36RvD55Jzf-mtGHejBeY9-DxXH2tSozKmjO_wtmkhdZXuQRfHMCtRu9d9jVkzMDuLs6o_WxujpWV3NVx-oi_HKxzs2A7T26dBXzV0sOXkPfObDa-AdjmSspWBa56sTd-gA7vAfABaN7PK7MSlkc1_LTEbc_pHtwNVr-F1VvuQM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15381686</pqid></control><display><type>article</type><title>Protein Binding of Quinolonecarboxylic Acids. II. : Spectral Changes on the Interaction of Cinoxacin, Nalidixic Acid and Pipemidic Acid with Human and Rat Albumins</title><source>J-STAGE Free</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>IZUMI, Taro ; NAGAYAMA, Takako ; KITAGAWA, Takayasu</creator><creatorcontrib>IZUMI, Taro ; NAGAYAMA, Takako ; KITAGAWA, Takayasu</creatorcontrib><description>The interaction of cinoxacin (CINX), nalidixic acid (NA), and pipemidic acid (PPA) with human and rat serum albumins (HSA and RSA) was studied by UV difference absorption and circular dichroism (CD) spectroscopy. CINX and NA bound to the albumins and generated difference absorption and induced CD (ICD) spectra. The difference absorption spectral data explained reasonably our previous observations that CINX bound to HSA more weakly than NA, but to RSA as strongly as NA. We used a quantity Δε/ε, designated as relative molar difference absorbance, at positions corresponding to the longest wavelength peaks in the difference spectra. The quantity was found to correlate linearly with percent bound to both HSA and RSA, but with different slopes, from which the binding site for CINX and NA in RSA was supposed to provide a much more nonpolar environment than that in HSA. The magnitude of ICD bands observed at 371 nm for CINX and at 342-348 nm for NA corresponded to the binding degrees of these drugs to both albumins. Anisotropy factors for the ICD bands at 350-271 nm for CINX and 320-348 nm for NA were approximately similar between HSA and RSA, suggesting a similar ability to generate the ICD spectra in these wavelength regions upon binding to the albumins. Spectral results for PPA in albumin solutions showed little or no binding of this drug to HSA and RSA. PPA existed as a betaine form in neutral solution and its positively charged group acted as an unfavorable factor for binding to both albumins.</description><identifier>ISSN: 0009-2363</identifier><identifier>EISSN: 1347-5223</identifier><identifier>DOI: 10.1248/cpb.37.746</identifier><identifier>PMID: 2752488</identifier><identifier>CODEN: CPBTAL</identifier><language>eng</language><publisher>Tokyo: The Pharmaceutical Society of Japan</publisher><subject>Animals ; anisotropy factor ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; betaine ; Biological and medical sciences ; cinoxacin ; Cinoxacin - blood ; human albumin ; Humans ; induced CD ; Medical sciences ; nalidixic acid ; Nalidixic Acid - blood ; Nicotinic Acids - blood ; Pharmacology. Drug treatments ; pipemidic acid ; Pipemidic Acid - blood ; protein binding ; Pyridazines - blood ; quinolonecarboxylic acids ; rat albumin ; Rats ; relative difference absorbance ; Serum Albumin - metabolism ; Spectrophotometry, Ultraviolet ; Spectrum Analysis</subject><ispartof>Chemical and Pharmaceutical Bulletin, 1989/03/25, Vol.37(3), pp.746-752</ispartof><rights>The Pharmaceutical Society of Japan</rights><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4496-b7d4a247c2a92fee2278c78f5359344e052d9ec0b8103b9e06d383fbd6553a5b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,1879,4012,27906,27907,27908</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19675421$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2752488$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>IZUMI, Taro</creatorcontrib><creatorcontrib>NAGAYAMA, Takako</creatorcontrib><creatorcontrib>KITAGAWA, Takayasu</creatorcontrib><title>Protein Binding of Quinolonecarboxylic Acids. II. : Spectral Changes on the Interaction of Cinoxacin, Nalidixic Acid and Pipemidic Acid with Human and Rat Albumins</title><title>Chemical & pharmaceutical bulletin</title><addtitle>Chem. Pharm. Bull.</addtitle><description>The interaction of cinoxacin (CINX), nalidixic acid (NA), and pipemidic acid (PPA) with human and rat serum albumins (HSA and RSA) was studied by UV difference absorption and circular dichroism (CD) spectroscopy. CINX and NA bound to the albumins and generated difference absorption and induced CD (ICD) spectra. The difference absorption spectral data explained reasonably our previous observations that CINX bound to HSA more weakly than NA, but to RSA as strongly as NA. We used a quantity Δε/ε, designated as relative molar difference absorbance, at positions corresponding to the longest wavelength peaks in the difference spectra. The quantity was found to correlate linearly with percent bound to both HSA and RSA, but with different slopes, from which the binding site for CINX and NA in RSA was supposed to provide a much more nonpolar environment than that in HSA. The magnitude of ICD bands observed at 371 nm for CINX and at 342-348 nm for NA corresponded to the binding degrees of these drugs to both albumins. Anisotropy factors for the ICD bands at 350-271 nm for CINX and 320-348 nm for NA were approximately similar between HSA and RSA, suggesting a similar ability to generate the ICD spectra in these wavelength regions upon binding to the albumins. Spectral results for PPA in albumin solutions showed little or no binding of this drug to HSA and RSA. PPA existed as a betaine form in neutral solution and its positively charged group acted as an unfavorable factor for binding to both albumins.</description><subject>Animals</subject><subject>anisotropy factor</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>betaine</subject><subject>Biological and medical sciences</subject><subject>cinoxacin</subject><subject>Cinoxacin - blood</subject><subject>human albumin</subject><subject>Humans</subject><subject>induced CD</subject><subject>Medical sciences</subject><subject>nalidixic acid</subject><subject>Nalidixic Acid - blood</subject><subject>Nicotinic Acids - blood</subject><subject>Pharmacology. Drug treatments</subject><subject>pipemidic acid</subject><subject>Pipemidic Acid - blood</subject><subject>protein binding</subject><subject>Pyridazines - blood</subject><subject>quinolonecarboxylic acids</subject><subject>rat albumin</subject><subject>Rats</subject><subject>relative difference absorbance</subject><subject>Serum Albumin - metabolism</subject><subject>Spectrophotometry, Ultraviolet</subject><subject>Spectrum Analysis</subject><issn>0009-2363</issn><issn>1347-5223</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAUhSMEKtPChj2SN7BAZHD8EyfshqjQkSoof-voxrmZcZU4wXbE9Hl4UTxM1C7Z2PI9n7-7OEnyIqPrjIninZ6aNVdrJfJHySrjQqWSMf44WVFKy5TxnD9Nzr2_pZRJqvhZcsaUjB-LVfLnxo0BjSUfjG2N3ZGxI19nY8d-tKjBNePhrjeabLRp_Zpst2vynnyfUAcHPan2YHfoyWhJ2CPZ2oAOdDDxHT1V1BxAG_uWfIbetOawiAjYltyYCYc4XEa_TdiTq3kA-y_9BoFs-mYejPXPkicd9B6fL_dF8vPj5Y_qKr3-8mlbba5TLUSZp41qBTChNIOSdYiMqUKropNcllwIpJK1JWraFBnlTYk0b3nBu6bNpeQgG36RvD55Jzf-mtGHejBeY9-DxXH2tSozKmjO_wtmkhdZXuQRfHMCtRu9d9jVkzMDuLs6o_WxujpWV3NVx-oi_HKxzs2A7T26dBXzV0sOXkPfObDa-AdjmSspWBa56sTd-gA7vAfABaN7PK7MSlkc1_LTEbc_pHtwNVr-F1VvuQM</recordid><startdate>1989</startdate><enddate>1989</enddate><creator>IZUMI, Taro</creator><creator>NAGAYAMA, Takako</creator><creator>KITAGAWA, Takayasu</creator><general>The Pharmaceutical Society of Japan</general><general>Maruzen</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M81</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>1989</creationdate><title>Protein Binding of Quinolonecarboxylic Acids. II. : Spectral Changes on the Interaction of Cinoxacin, Nalidixic Acid and Pipemidic Acid with Human and Rat Albumins</title><author>IZUMI, Taro ; NAGAYAMA, Takako ; KITAGAWA, Takayasu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4496-b7d4a247c2a92fee2278c78f5359344e052d9ec0b8103b9e06d383fbd6553a5b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Animals</topic><topic>anisotropy factor</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>betaine</topic><topic>Biological and medical sciences</topic><topic>cinoxacin</topic><topic>Cinoxacin - blood</topic><topic>human albumin</topic><topic>Humans</topic><topic>induced CD</topic><topic>Medical sciences</topic><topic>nalidixic acid</topic><topic>Nalidixic Acid - blood</topic><topic>Nicotinic Acids - blood</topic><topic>Pharmacology. Drug treatments</topic><topic>pipemidic acid</topic><topic>Pipemidic Acid - blood</topic><topic>protein binding</topic><topic>Pyridazines - blood</topic><topic>quinolonecarboxylic acids</topic><topic>rat albumin</topic><topic>Rats</topic><topic>relative difference absorbance</topic><topic>Serum Albumin - metabolism</topic><topic>Spectrophotometry, Ultraviolet</topic><topic>Spectrum Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>IZUMI, Taro</creatorcontrib><creatorcontrib>NAGAYAMA, Takako</creatorcontrib><creatorcontrib>KITAGAWA, Takayasu</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 3</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Chemical & pharmaceutical bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>IZUMI, Taro</au><au>NAGAYAMA, Takako</au><au>KITAGAWA, Takayasu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protein Binding of Quinolonecarboxylic Acids. II. : Spectral Changes on the Interaction of Cinoxacin, Nalidixic Acid and Pipemidic Acid with Human and Rat Albumins</atitle><jtitle>Chemical & pharmaceutical bulletin</jtitle><addtitle>Chem. Pharm. Bull.</addtitle><date>1989</date><risdate>1989</risdate><volume>37</volume><issue>3</issue><spage>746</spage><epage>752</epage><pages>746-752</pages><issn>0009-2363</issn><eissn>1347-5223</eissn><coden>CPBTAL</coden><abstract>The interaction of cinoxacin (CINX), nalidixic acid (NA), and pipemidic acid (PPA) with human and rat serum albumins (HSA and RSA) was studied by UV difference absorption and circular dichroism (CD) spectroscopy. CINX and NA bound to the albumins and generated difference absorption and induced CD (ICD) spectra. The difference absorption spectral data explained reasonably our previous observations that CINX bound to HSA more weakly than NA, but to RSA as strongly as NA. We used a quantity Δε/ε, designated as relative molar difference absorbance, at positions corresponding to the longest wavelength peaks in the difference spectra. The quantity was found to correlate linearly with percent bound to both HSA and RSA, but with different slopes, from which the binding site for CINX and NA in RSA was supposed to provide a much more nonpolar environment than that in HSA. The magnitude of ICD bands observed at 371 nm for CINX and at 342-348 nm for NA corresponded to the binding degrees of these drugs to both albumins. Anisotropy factors for the ICD bands at 350-271 nm for CINX and 320-348 nm for NA were approximately similar between HSA and RSA, suggesting a similar ability to generate the ICD spectra in these wavelength regions upon binding to the albumins. Spectral results for PPA in albumin solutions showed little or no binding of this drug to HSA and RSA. PPA existed as a betaine form in neutral solution and its positively charged group acted as an unfavorable factor for binding to both albumins.</abstract><cop>Tokyo</cop><pub>The Pharmaceutical Society of Japan</pub><pmid>2752488</pmid><doi>10.1248/cpb.37.746</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-2363 |
ispartof | Chemical and Pharmaceutical Bulletin, 1989/03/25, Vol.37(3), pp.746-752 |
issn | 0009-2363 1347-5223 |
language | eng |
recordid | cdi_proquest_miscellaneous_79104063 |
source | J-STAGE Free; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Free Full-Text Journals in Chemistry |
subjects | Animals anisotropy factor Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents betaine Biological and medical sciences cinoxacin Cinoxacin - blood human albumin Humans induced CD Medical sciences nalidixic acid Nalidixic Acid - blood Nicotinic Acids - blood Pharmacology. Drug treatments pipemidic acid Pipemidic Acid - blood protein binding Pyridazines - blood quinolonecarboxylic acids rat albumin Rats relative difference absorbance Serum Albumin - metabolism Spectrophotometry, Ultraviolet Spectrum Analysis |
title | Protein Binding of Quinolonecarboxylic Acids. II. : Spectral Changes on the Interaction of Cinoxacin, Nalidixic Acid and Pipemidic Acid with Human and Rat Albumins |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T23%3A15%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protein%20Binding%20of%20Quinolonecarboxylic%20Acids.%20II.%20:%20Spectral%20Changes%20on%20the%20Interaction%20of%20Cinoxacin,%20Nalidixic%20Acid%20and%20Pipemidic%20Acid%20with%20Human%20and%20Rat%20Albumins&rft.jtitle=Chemical%20&%20pharmaceutical%20bulletin&rft.au=IZUMI,%20Taro&rft.date=1989&rft.volume=37&rft.issue=3&rft.spage=746&rft.epage=752&rft.pages=746-752&rft.issn=0009-2363&rft.eissn=1347-5223&rft.coden=CPBTAL&rft_id=info:doi/10.1248/cpb.37.746&rft_dat=%3Cproquest_cross%3E79104063%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15381686&rft_id=info:pmid/2752488&rfr_iscdi=true |